Skip to main content

Table 1 Baseline characteristics according to values below median (more negative) (n = 65) or above median (more positive) (n = 52), median GLS (median = −11 %)

From: Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure

Variable Below median GLS Above median GLS p-value
(n = 65) (n = 52)
Age, years 69 (63–76) 71 (67–76) 0.761
Female gender, % 33.8 21.2 0.130
BMIa, kg/m2 26.0 (22.6-30.2) 26.3 (24.5-30.3) 0.214
NYHAb class III-IV, % 23.1 30.8 0.349
Systolic BPc, mmHg 132 (120–147) 120 (110–140) 0.178
Diastolic BPc, mmHg 77 (70–82) 77 (69–84) 0.889
Heart rate, beats/min 64 (56–76) 70 (62–78) 0.188
HFd duration, months 9 (6–12) 12 (6–24) 0.216
Pervious MIe, % 33.8 44.2 0.251
Hypertension, % 67.7 59.6 0.395
Atrial fibrillation, % 24.6 40.4 0.068
ICDf, % 9.5 13.5 0.507
Diabetes, % 20 25 0.518
ApoplexiaCerebri/TCIg, % 12.3 23.1 0.124
ACE-Ih, % 73.8 59.6 0.140
ARBi, % 21.5 32.7 0.174
Beta-blocker, % 87.7 86.5 0.853
MRAj, % 14.1 28.8 0.051
Diuretics, % 69.2 76.9 0.354
Hemoglobine, mmol/l 8.5 (7.0-9.0) 8.8 (8.0-9.3) 0.215
Creatinine, umol/l 80 (68–97) 95 (73–119) 0.254
eGFRk, ml/min/1,73 m2 82 (66–98) 70 (51–95) 0.244
  1. aBody mass index, bNew York Heart Association, cBlood pressure, dHeart failure, eMyocardial infarction, fImplantable cardiac defibrillator, gTransitory cerebral ischemia, hAngiotensin converting enzyme inhibitor, iAldosterone receptor blocker, jMineralocorticoid receptor antagonist, kEstimated glomerular filtration rate